NCI clinical trial showed reduced intervals between chemotherapy improved survival in women whose breast cancer had spread to lymph nodes
On Dec. 12, 2002, a National Cancer Institute announced that a clinical trial had shown that reducing the…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | U.S. Congress | Women's Health
President Bush signed appropriations to reauthorize the Breast Cancer Research Postage Stamp
On Nov. 12, 2001, the President George W. Bush signed P.L. 107-67 making appropriations for the Treasury Department,…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
President Bill Clinton signed into law the Semipostal Authorization Act
On Jul. 28, 2000, President Bill Clinton signed into law the Semipostal Authorization Act (P.L. 106-253), which gave…
Siteman Cancer Center investigators joined the STAR (Study of Tamoxifen and Raloxifene) trial for breast cancer prevention
In 1999, Siteman Cancer Center investigators joined the STAR (Study of Tamoxifen and Raloxifene) trial for breast cancer…
Biotechnology | Diagnostics | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
Breast Cancer Prevention Trial Results published
On Sept. 14, 1998, researchers from the Breast Cancer Prevention Trial (BCPT) published a full report and update…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer stamp was first issued
On Jul. 29, 1998, the Stamp Out Breast Cancer stamp was first issued. The driving force behind the…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Oncology | Radiology | Therapeutics
Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, reduced the incidence of some breast cancer outcomes
In 1998, Tamoxifen, created with the MCF-7 breast cancer cell line established by Karmanos, was revealed to reduce…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | U.S. Congress | Women's Health
The Stamp Out Breast Cancer Act (PL 105-41) was signed into law
On Aug. 13, 1997, the Stamp Out Breast Cancer Act (PL 105-41) was signed into law by President…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | U.S. Congress | Women's Health
the Art behind the Breast Cancer Research Postage Stamp
In August 1997, the U.S. Congress passed legislation that directed the U.S. Postal Service to issue its first…
Scientists cloned the tumor suppressor genes BRCA1 and BRCA2
In 1995, scientists cloned the tumor suppressor genes BRCA1 and BRCA2, inherited genetic mutations that can predict an…
BRCA2 gene mapped to chromosome 13q12-13
In 1995, The BRCA2 gene was mapped to chromosomal 13q. Just fifteen months later, Wooster et al.5 reported…
Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington
In 1995, Mary-Claire King, an internationally known human geneticist, was recruited to the University of Washington’s (UW) School…
Bristol-Myers Squibb launched TAXOL (paclitaxel)
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
Washington University School of Medicine announced as a participating site for the prostate, lung, colorectal, and ovarian cancers (PLCO study)
In 1993, the Washington University School of Medicine announced that it was a participating site for the prostate,…
The Mammography Quality Standards Act was passed
On Oct. 27, 1992, the Mammography Quality Standards Act (MQSA) was passed (P.L. 102-539) by the U.S. Congress….
The CDC began developing a national strategic plan for early detection and control of breast and cervical cancers
In 1991, the U.S. Centers for Disease Control and Prevention (CDC) began developing a national strategic plan for…
Karmanos Cancer Institute researcher Dr. Soule developed MCF-10, an immortal line of normal human breast cells
In 1989, Karmanos Cancer Institute researcher Dr. Soule developed MCF-10, an immortal line of normal human breast cells….
The Mallinckrodt of Radiology introduced the first mobile mammography unit in the St. Louis region
In 1986, the Mallinckrodt Institute of Radiology and the former Barnes Hospital introduced the first mobile mammography unit…
Scientists discovered the HER2 gene
In 1985, the HER2 oncogene was discovered by Axel Ullrich, a young scientist at Genentech. The new oncogene…
Lumpectomy plus radiation therapy is found equivalent to mastectomy for early breast cancer
In 1985, Lumpectomy plus radiation therapy was found equivalent to mastectomy for early breast cancer. Lumpectomy followed by…
Fluoroestradiol was first developed by Washington University at St. Louis researcher
In 1984, fluoroestradiol (FES) was first developed by researchers Michael J. Welch, PhD from Washington University at St….
Karmanos Cancer Institute researcher Herbert Soule, PhD developed the MCF-7 human breast cancer cell line
In 1973, Karmanos Cancer Institute researcher Herbert Soule, Ph.D. developed the MCF-7 human breast cancer cell line, which…
The Wistar Institute was designated a National Cancer Institute Cancer Center
In 1972, The Wistar Institute was designated the first National Cancer Institute (NCI) Cancer Center in basic research…